Preclinical Outsourcing
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Labs Acquires Distributed Bio
Establishes integrated, large molecule discovery platform.Contract Pharma Staff 01.04.21
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Online Exclusives Kristin Brooks, Contract Pharma 10.20.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
Paves the way towards getting OCU200 in the clinic by first half of 2022.Contract Pharma Staff 10.06.20
-
Drug Development | Preclinical Outsourcing
Preclinical Planning for Successful Drug Development
When the preclinical pressure is on, appropriate planning can make sure timelines are achievable.Mingyi Trimble, WuXi AppTec 09.09.20
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
Evotec, Samsara BioCapital, and KCK Launch Autobahn Labs
A novel early stage drug discovery incubator.Contract Pharma Staff 06.24.20
-
Analytical Services | Breaking News | CRO News | Drug Development | Industry News | Preclinical Outsourcing
Frontage Establishes Center of Excellence
Quantitative whole-body autoradiography CoE will be located in Exton, PA and headed by Michael Potchobia.Contract Pharma Staff 06.02.20
-
CRO News | Preclinical Outsourcing
Rho, TRI Partner on Risk-Based Quality Management
Technology platform aims to optimize trial quality by improving data reliability, patient safety and operational efficiency01.14.20
-
Biologics, Proteins, Vaccines | CRO News | Drug Discovery | Preclinical Outsourcing
Charles River to Acquire HemaCare Corp. for $380M
Expands scientific capabilities for cell and gene therapies12.16.19
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
Charles River Provides Access to Cosmic Antibody Library
Expanded antibody library launched by Distributed Bio aims to expedite the drug discovery process12.12.19
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
BioIVT Acquires PPA Research Group
Expands product portfolio to support immuno-oncology and cell therapy research10.18.19
-
Industry News | Preclinical Outsourcing
Genesis Aquires NexusPharma
Expands preclinical contract research portfolio and integrates unique xenograft models06.18.19
-
Drug Development | Preclinical Outsourcing
New Drug Development Strategies Needed for Alzheimer’s Treatments
Selecting a single CRO partner that can take CNS compounds from functional screening in vitro through in vivo and beyondBirgit Hutter-Paier, Senior Director and Head of Neuropharmacology, QPS 05.10.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Preclinical Outsourcing | Process Development
WuXi STA Forms Partnership with Beta Pharma
STA will accelerate process R&D and manufacturing of late phase and commercial targets03.21.19
-
Breaking News | Industry News | Laboratory Testing | Preclinical Outsourcing
-
Drug Development | Preclinical Outsourcing
Early Development Trends
Catalent’s president of oral drug delivery, Jonathan Arnold, talks trends and challenges in the early phases of drug development.Tim Wright, Editor, Contract Pharma 03.06.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
Valitacell, Solentim Form Biologics Collaboration
Goal is to enable earlier identification of biological candidates02.22.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Preclinical Outsourcing
Janssen, Morphic Ink Deal Worth up to $750M
Deal extends reach of Morphic discovery across all known human integrins02.22.19
-
Breaking News | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Alkermes, Clovis Form Cancer Research Collaboration
Together will explore combination cancer therapies02.20.19
-
Breaking News | CRO News | Industry News | Preclinical Outsourcing
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
